Cargando…
Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation
To date, therapeutic method for in vivo gene delivery has not been established on bone engineering though its potential usefulness has been suggested. For clinical applications, an effective condition should be developed to transfer the genes in vivo without any transfection reagents or virus vector...
Autores principales: | Umebayashi, Mayumi, Sumita, Yoshinori, Kawai, Yousuke, Watanabe, Sumiko, Asahina, Izumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497668/ https://www.ncbi.nlm.nih.gov/pubmed/26309793 http://dx.doi.org/10.1089/biores.2014.0057 |
Ejemplares similares
-
Gene-activated matrix harboring a miR20a-expressing plasmid promotes rat cranial bone augmentation
por: Shido, Rena, et al.
Publicado: (2021) -
Gene-Activated Matrix with Self-Assembly Anionic Nano-Device Containing Plasmid DNAs for Rat Cranial Bone Augmentation
por: Hara, Masahito, et al.
Publicado: (2021) -
Bone marrow concentrate promotes bone regeneration with a suboptimal-dose of rhBMP-2
por: Egashira, Kazuhiro, et al.
Publicado: (2018) -
Intra-Bone Marrow Administration of Mesenchymal Stem/Stromal Cells Is a Promising Approach for Treating Osteoporosis
por: Agata, Hideki, et al.
Publicado: (2019) -
Arthroscopic microfracture with atelocollagen augmentation for osteochondral lesion of the talus: a multicenter randomized controlled trial
por: Lee, Young Koo, et al.
Publicado: (2020)